November 29, 20091Cancer Vaccines: Investing Opportunities Beyond Dendreon Despite the setbacks and pitfalls experienced by early-stage pioneers in the cancer immunotherapy / therapeutic cancer vaccine space, recent advancements and study results are encouraging.
